KORTUC is a pioneering brand dedicated to increasing the power of cancer radiotherapy. They have developed an innovative solution to address the most fundamental issue in cancer treatment, hypoxia. By injecting their groundbreaking radiosensitizer, primarily composed of H2O2, into tumors, KORTUC effectively eliminates hypoxia and enhances the effectiveness of radiotherapy while ensuring safety.

As a company, KORTUC's mission is to provide more options for cancer radiotherapy. They offer a unique radiosensitizer that maximizes the efficacy of radiotherapy, revolutionizing the way this treatment is administered. With their cutting-edge technology, KORTUC aims to transform the landscape of cancer treatment.

Their commitment to ongoing research and development is evident through their latest activities. They have recently published articles in prestigious medical journals such as Cancer Science and Oncology Letters, showcasing the groundbreaking potential of their product, KRC-01. Additionally, KORTUC actively participates in international conferences to present their new basic research results.

Discover more about KORTUC's remarkable journey, their innovative technology, upcoming developments, and the dedicated team behind the brand by exploring their website. KORTUC is at the forefront of improving cancer radiotherapy, with a profound dedication to positively impact society and improve patient outcomes